SATELLITE patient understanding of atrial fibrillation therapies at baseline and at 6 months
| Survey question (N) | Understanding at baseline | Understanding at 6-month follow-up | ||
| Panel A: role of rhythm control (n=589) | All | High understanding | Moderate understanding | Low understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 71.3 | 79.8 | 12.6 | 7.6 |
| Moderate understanding | 15.4 | 53.9 | 27.5 | 18.7 |
| Low understanding | 13.2 | 50.0 | 19.2 | 30.8 |
| Weighted kappa=0.26 (0.18, 0.33) | ||||
| Panel B: options for rhythm control (n=581) | All | High understanding | Moderate understanding | Low understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 44.8 | 63.5 | 19.2 | 17.3 |
| Moderate understanding | 26.9 | 43.6 | 30.8 | 25.6 |
| Low understanding | 28.4 | 28.5 | 24.9 | 46.7 |
| Weighted kappa=0.27 (0.20, 0.34) | ||||
| Panel C: role of ablation (n=546) | All | High understanding | Moderate understanding | Low understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 44.3 | 66.1 | 12.4 | 21.5 |
| Moderate understanding | 22.2 | 31.4 | 36.4 | 32.2 |
| Low understanding | 33.5 | 32.8 | 15.9 | 51.4 |
| Weighted kappa=0.30 (0.23, 0.37) | ||||
| Panel D: options for ablation (n=578) | All | High understanding | Moderate understanding | Low understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 35.3 | 55.4 | 22.1 | 22.6 |
| Moderate understanding | 25.4 | 30.6 | 34.0 | 35.4 |
| Low understanding | 39.3 | 22.9 | 19.4 | 57.7 |
| Weighted kappa=0.30 (0.23, 0.36) | ||||
| Panel E: benefits of cardioversions (n=743) | All | High understanding | Low understanding | No understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 47.1 | 78.9 | 16.6 | 4.6 |
| Low understanding | 38.2 | 34.9 | 53.9 | 11.3 |
| No understanding | 14.7 | 22.9 | 41.3 | 35.8 |
| Weighted kappa=0.42 (0.36, 0.47) | ||||
| Panel F: benefits of warfarin (n=724) | All | High understanding | Low understanding | No understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 45.6 | 77.9 | 19.1 | 3.0 |
| Low understanding | 41.4 | 47.0 | 49.0 | 4.0 |
| No understanding | 13.0 | 31.9 | 44.7 | 23.4 |
| Weighted kappa=0.32 (0.26, 0.37) | ||||
| Panel G: benefits of DOACs (n=738) | All | High understanding | Low understanding | No understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 50.0 | 84.0 | 14.6 | 1.4 |
| Low understanding | 39.4 | 59.1 | 38.5 | 2.4 |
| No understanding | 10.6 | 32.1 | 44.9 | 23.1 |
| Weighted kappa=0.30 (0.24, 0.36) | ||||
| Panel H: benefits of left atrial appendage closure (n=734) | All | High understanding | Low understanding | No understanding |
| Baseline understanding | % | % | % | % |
| High understanding | 8.5 | 32.3 | 22.6 | 45.2 |
| Low understanding | 25.3 | 13.4 | 41.9 | 44.6 |
| No understanding | 66.2 | 6.0 | 20.8 | 73.3 |
| Weighted kappa=0.26 (0.20, 0.33) | ||||
DOACs, direct oral anticoagulants.